Inhibition of the mitochondrial protein Opa1 curtails breast cancer growth
Abstract Background Mitochondrial fusion and fission proteins have been nominated as druggable targets in cancer.Whether their escrima stick inhibition is efficacious in triple negative breast cancer (TNBC) that almost invariably develops chemoresistance is unknown.Methods We used a combination of bioinformatics analyses of cancer genomic databases